X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Tom Wilbur

Tom Wilbur is Senior Director of Public Affairs at PhRMA focused on opinion research, message development and political communications. Prior to joining PhRMA in 2019, Tom worked on Capitol Hill and on political campaigns for eight years, most recently responsible for communications and strategy for U.S. Rep. Fred Upton and the House Energy and Commerce Committee. Tom is a proud Michigander and outside of the office enjoys spending time with friends and family, reading, running, hiking, and golfing.

Recent Posts

In their own words: Insured Americans struggle to navigate complex coverage

By Tom Wilbur  |    October 26, 2022
A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.   Read More

Polling continues to show voters reject so-called Medicare “negotiation” once they learn about consequences for patients

By Tom Wilbur  |    July 12, 2022
As policymakers race to pass government price setting policies, it’s important to examine true public sentiment around such proposals. Voters have made clear that they do not support policies such as...   Read More

5 public opinion polling trends to watch

By Tom Wilbur  |    April 22, 2022
Today, we’re taking a closer look at Americans’ leading concerns and what issues they want policymakers to prioritize.   Read More

Legislation threatens patent protections and future innovation

By Tom Wilbur  |    January 12, 2022
Recently introduced legislation, the “Restoring the America Invents Act (RAIA),” if enacted, would push the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office to grant more...   Read More

Three things to know about so-called Medicare negotiation polling

By Tom Wilbur  |    November 18, 2021
As policymakers continue to push partisan drug pricing proposals, several polls misrepresenting voter opinion have been circulated to try and justify these flawed policies. These polls fail to...   Read More

Recent polling misrepresents public support for Medicare “negotiation”

By Tom Wilbur  |    August 31, 2021
Proponents of government price setting often misrepresent voters’ opinions on support for allowing the federal government to “negotiate” drug prices. This includes recent polling from advocacy firms...   Read More

Myth vs. fact: Polling and Medicare “negotiation”

By Tom Wilbur  |    August 12, 2021
As some in Washington consider legislation related to prescription medicines and how to best help Americans manage health care costs, government “negotiation” of prescription medicines within...   Read More

Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery

By Tom Wilbur  |    July 2, 2021
As we head into the Fourth of July weekend, Americans are reemerging from the COVID-19 pandemic with heightened hopes and confidence in a strong U.S. recovery. The COVID-19 vaccines have been...   Read More

Four solutions Americans support to make health care more affordable

By Tom Wilbur  |    May 13, 2021
Health care costs and affordability remain a major challenge for most Americans, even among those with insurance. According to a March Gallup poll, nearly one-in-five (18%) U.S. adults report that if...   Read More

ICYMI: Bipartisan lawmakers urge new administration to oppose changes to six protected classes policy

By Tom Wilbur  |    March 11, 2021
On January 19, 2021 – the last full day of the Trump administration – CMS released a Part D Payment Modernization Model Request for Applications (RFA) for calendar year 2022. This model would provide...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates